Stargazer Pharmaceuticals’ $57 Million Series A Financing

Wilson Sonsini Goodrich & Rosati advised Stargazer Pharmaceuticals, Inc. on the deal. Stargazer Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel treatment options…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here